Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cashflow Statement

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹2.02 Cr₹57 Cr₹55 Cr₹44 Cr₹8.79 Cr
Adjustment ₹-1.14 Cr₹8.03 Cr₹1.18 Cr₹-0.59 Cr₹0.03 Cr
Changes In working Capital ₹11 Cr₹-47 Cr₹-16 Cr₹-41 Cr₹-22 Cr
Cash Flow after changes in Working Capital ₹12 Cr₹18 Cr₹40 Cr₹2.60 Cr₹-13 Cr
Cash Flow from Operating Activities ₹4.87 Cr₹6.08 Cr₹34 Cr₹0.00 Cr₹-14 Cr
Cash Flow from Investing Activities ₹-1.05 Cr₹-11 Cr₹-28 Cr₹-5.97 Cr₹-0.18 Cr
Cash Flow from Financing Activities ₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr₹18 Cr
Net Cash Inflow / Outflow ₹34 Cr₹21 Cr₹5.53 Cr₹-2.32 Cr₹3.88 Cr
Opening Cash & Cash Equivalents ₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr₹0.10 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr

Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹287.0 Cr 1.9% -3.8% -52.1% Stock Analytics
ADANI ENTERPRISES ₹289,313.0 Cr 0.2% 3.3% -19.8% Stock Analytics
REDINGTON ₹23,074.1 Cr 5.9% 7.8% 37.3% Stock Analytics
MMTC ₹10,432.5 Cr -3.2% 20.1% 3.6% Stock Analytics
HONASA CONSUMER ₹9,983.1 Cr -2.5% 21.6% -27.7% Stock Analytics
LLOYDS ENTERPRISES ₹9,403.6 Cr 3.5% 36.9% 120% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

1.9%

-3.8%

-52.1%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses